Validation and comparison of quality‐of‐life measures for topical 5‐fluorouracil treatment: results from a randomized controlled trial

Summary Background Topical 5‐fluorouracil (5‐FU) is commonly used for high‐risk patients with keratinocyte carcinoma (KC). Skindex and Skin Cancer Index (SCI) are validated instruments to measure quality of life (QoL) of patients with KC and those who have had surgical treatment of KCs. Aim To valid...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and experimental dermatology 2017-07, Vol.42 (5), p.488-495
Hauptverfasser:	Pomerantz, H., Chren, M.‐M., Lew, R., Weinstock, M. A., Hogan, D, Eilers, D., Swetter, S., Chen, S. C., Jacob, S., Warshaw, E. M., Stricklin, G., Dellavalle, R. P., Konnikov, N., Werth, V., Sidhu‐Malik, N., Keri, J., Swan, J. W., Nord, K., Pollack, B., Kempiak, S., High, W., Fett, N., Hall, R.l P., Alonso‐Llamazares, J.r, Rodriguez, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	5-Fluorouracil Administration, Cutaneous Analysis of Variance Cream Female Fluorouracil - therapeutic use Humans Male Quality of Life Risk groups Skin cancer Skin Neoplasms - prevention & control Surveys and Questionnaires Toxicity Veterans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!